These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 6508320

  • 1. [Spergualin a novel antitumor antibiotic produced by Bacillus laterosporus].
    Takeuchi T.
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2633-9. PubMed ID: 6508320
    [Abstract] [Full Text] [Related]

  • 2. Spergualin: a new antitumour antibiotic.
    Umezawa K, Takeuchi T.
    Biomed Pharmacother; 1987 Dec; 41(5):227-32. PubMed ID: 3499181
    [Abstract] [Full Text] [Related]

  • 3. [Spergualin, a new antitumor antibiotic].
    Takeuchi T.
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):845-9. PubMed ID: 3566295
    [Abstract] [Full Text] [Related]

  • 4. Involvement of cytotoxic T-lymphocytes in the antitumor activity of spergualin against L1210 cells.
    Umezawa H, Nishikawa K, Shibasaki C, Takahashi K, Nakamura T, Takeuchi T.
    Cancer Res; 1987 Jun 15; 47(12):3062-5. PubMed ID: 3495325
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A new antitumor antibiotic, spergualin: isolation and antitumor activity.
    Takeuchi T, Iinuma H, Kunimoto S, Masuda T, Ishizuka M, Takeuchi M, Hamada M, Naganawa H, Kondo S, Umezawa H.
    J Antibiot (Tokyo); 1981 Dec 15; 34(12):1619-21. PubMed ID: 7333976
    [No Abstract] [Full Text] [Related]

  • 9. Cytotoxicity of spergualin and amine oxidase activity in medium.
    Kunimoto S, Miura K, Iinuma H, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1985 Jul 15; 38(7):899-903. PubMed ID: 4030503
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and antitumor activity of spergualin analogues. II. Chemical modification of the spermidine moiety.
    Umeda Y, Moriguchi M, Kuroda H, Nakamura T, Fujii A, Iinuma H, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1987 Sep 15; 40(9):1303-15. PubMed ID: 3680040
    [Abstract] [Full Text] [Related]

  • 11. Antitumor spectrum of deoxyspergualin and its lack of cross-resistance to other antitumor agents.
    Nishikawa K, Shibasaki C, Hiratsuka M, Arakawa M, Takahashi K, Takeuchi T.
    J Antibiot (Tokyo); 1991 Oct 15; 44(10):1101-9. PubMed ID: 1955393
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and biological activity of spergualin analogues. I.
    Nishizawa R, Takei Y, Yoshida M, Tomiyoshi T, Saino T, Nishikawa K, Nemoto K, Takahashi K, Fujii A, Nakamura T.
    J Antibiot (Tokyo); 1988 Nov 15; 41(11):1629-43. PubMed ID: 3242505
    [Abstract] [Full Text] [Related]

  • 13. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV, Wallace RE, Murdock KC, Angier RB, Durr FE, Forbes M.
    Cancer Res; 1982 Feb 15; 42(2):440-4. PubMed ID: 7055799
    [Abstract] [Full Text] [Related]

  • 14. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L, Rosato A, Napoli E, Sola F, Geroni C, Floreani M, Zanovello P.
    Cancer Res; 2000 Jun 15; 60(12):3232-8. PubMed ID: 10866316
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.